Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 18362 | 41.41 |
09:34 ET | 2129 | 40.48 |
09:38 ET | 17475 | 40.215 |
09:39 ET | 1999 | 40.01 |
09:41 ET | 2000 | 40.125 |
09:45 ET | 200 | 40.125 |
09:48 ET | 1092 | 40.24 |
09:50 ET | 4810 | 40.15 |
09:52 ET | 14423 | 39.9931 |
09:54 ET | 1000 | 39.98 |
09:56 ET | 200 | 39.915 |
09:57 ET | 900 | 39.93 |
09:59 ET | 3800 | 39.985 |
10:01 ET | 1152 | 40.06 |
10:03 ET | 4100 | 40.44 |
10:06 ET | 10225 | 40.33 |
10:08 ET | 1010 | 40.19 |
10:10 ET | 700 | 40.35 |
10:12 ET | 800 | 40.255 |
10:14 ET | 1300 | 40.33 |
10:15 ET | 200 | 40.4 |
10:17 ET | 1931 | 40.47 |
10:19 ET | 340 | 40.33 |
10:21 ET | 23585 | 40.23 |
10:26 ET | 100 | 40.1405 |
10:28 ET | 2450 | 40.4 |
10:30 ET | 212 | 40.41 |
10:32 ET | 100 | 40.5 |
10:33 ET | 1136 | 40.715 |
10:35 ET | 146 | 40.72 |
10:37 ET | 550 | 40.65 |
10:39 ET | 200 | 40.78 |
10:42 ET | 1425 | 40.66 |
10:46 ET | 700 | 40.535 |
10:48 ET | 642 | 40.44 |
10:50 ET | 815 | 40.5099 |
10:51 ET | 900 | 40.34 |
10:53 ET | 7403 | 40.45 |
10:55 ET | 1350 | 40.4 |
10:57 ET | 1400 | 40.58 |
11:00 ET | 253 | 40.64 |
11:04 ET | 344 | 40.454 |
11:06 ET | 1680 | 40.43 |
11:08 ET | 1955 | 40.555 |
11:09 ET | 600 | 40.42 |
11:11 ET | 200 | 40.36 |
11:13 ET | 1771 | 40.485 |
11:15 ET | 100 | 40.49 |
11:18 ET | 700 | 40.27 |
11:20 ET | 100 | 40.27 |
11:22 ET | 1400 | 40.385 |
11:26 ET | 7228 | 40.62 |
11:27 ET | 2545 | 40.73 |
11:29 ET | 6200 | 40.71 |
11:31 ET | 700 | 40.625 |
11:36 ET | 854 | 40.61 |
11:38 ET | 400 | 40.605 |
11:40 ET | 655 | 40.605 |
11:42 ET | 2100 | 40.675 |
11:44 ET | 600 | 40.57 |
11:45 ET | 700 | 40.59 |
11:47 ET | 29187 | 40.55 |
11:49 ET | 600 | 40.475 |
11:51 ET | 200 | 40.475 |
11:54 ET | 1728 | 40.3801 |
11:56 ET | 500 | 40.465 |
11:58 ET | 12480 | 40.42 |
12:00 ET | 5286 | 40.425 |
12:02 ET | 490 | 40.45 |
12:03 ET | 548 | 40.5 |
12:05 ET | 900 | 40.48 |
12:14 ET | 1700 | 40.39 |
12:16 ET | 5395 | 40.41 |
12:18 ET | 1200 | 40.43 |
12:20 ET | 1469 | 40.39 |
12:21 ET | 5342 | 40.47 |
12:23 ET | 100 | 40.47 |
12:25 ET | 2284 | 40.49 |
12:27 ET | 400 | 40.515 |
12:30 ET | 2878 | 40.485 |
12:32 ET | 500 | 40.49 |
12:38 ET | 571 | 40.49 |
12:39 ET | 100 | 40.46 |
12:41 ET | 4414 | 40.58 |
12:43 ET | 100 | 40.51 |
12:48 ET | 2481 | 40.3 |
12:50 ET | 1100 | 40.27 |
12:52 ET | 1231 | 40.215 |
12:54 ET | 6000 | 40.25 |
12:56 ET | 9676 | 40.225 |
12:57 ET | 1500 | 40.2 |
12:59 ET | 20218 | 40.065 |
01:01 ET | 10513 | 40.085 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 2.3B | -17.2x | --- |
Verona Pharma PLC | 2.3B | -17.3x | --- |
Vera Therapeutics Inc | 2.2B | -17.8x | --- |
Janux Therapeutics Inc | 2.3B | -47.9x | --- |
Celldex Therapeutics Inc | 2.4B | -13.0x | --- |
CG Oncology Inc | 2.5B | -30.6x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.3B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -17.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.